The injection of RBA into RA joints blocks the ERK/HIF-1α/GLUT1 signaling pathway, promotes phenotype transformation of macrophages, inhibits inflammatory cytokines and enhances tissue repair. Here, SLC2A1 is linked to rheumatoid arthritis.